Trevi Therapeutics is developing nalbuphine ER (Haduvio) for chronic cough in IPF and RCC, targeting unmet medical needs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback